Jazz Pharmaceuticals Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results. Needham Reiterated a Buy Rating on the Stock.
Jazz Pharmaceuticals Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results. Needham Reiterated a Buy Rating on the Stock.
爵士製藥股價上漲,公司公佈了好於預期的第三季度財務業績後。 Needham重申對該股的買入評級。
Jazz Pharmaceuticals Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results. Needham Reiterated a Buy Rating on the Stock.
爵士製藥股票交易上漲,公司公佈了好於預期的第三季度財務業績。 Needham重申對該股的買入評級。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。